BRUNELLO, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 18.857
AS - Asia 9.214
EU - Europa 8.443
SA - Sud America 1.334
Continente sconosciuto - Info sul continente non disponibili 342
AF - Africa 196
OC - Oceania 39
Totale 38.425
Nazione #
US - Stati Uniti d'America 18.447
SG - Singapore 3.126
GB - Regno Unito 2.116
CN - Cina 2.022
DE - Germania 1.703
IT - Italia 1.697
HK - Hong Kong 1.299
BR - Brasile 1.084
VN - Vietnam 877
SE - Svezia 712
BD - Bangladesh 566
RU - Federazione Russa 556
FI - Finlandia 393
KR - Corea 268
FR - Francia 250
UA - Ucraina 250
CA - Canada 241
IN - India 228
TR - Turchia 211
BG - Bulgaria 177
ID - Indonesia 101
IE - Irlanda 94
JP - Giappone 91
NL - Olanda 85
AR - Argentina 84
MX - Messico 83
PL - Polonia 80
ES - Italia 66
IQ - Iraq 62
ZA - Sudafrica 59
AE - Emirati Arabi Uniti 55
PK - Pakistan 46
EC - Ecuador 43
CH - Svizzera 39
CZ - Repubblica Ceca 39
AU - Australia 36
BE - Belgio 31
UZ - Uzbekistan 31
CO - Colombia 30
EG - Egitto 30
VE - Venezuela 27
RO - Romania 25
PH - Filippine 23
LT - Lituania 22
SA - Arabia Saudita 21
CL - Cile 20
MA - Marocco 20
TH - Thailandia 20
DZ - Algeria 19
JO - Giordania 19
AT - Austria 18
MY - Malesia 18
IR - Iran 17
IL - Israele 16
KE - Kenya 16
PY - Paraguay 16
TW - Taiwan 16
JM - Giamaica 14
TN - Tunisia 14
AZ - Azerbaigian 13
CR - Costa Rica 13
GR - Grecia 12
PE - Perù 12
DK - Danimarca 11
KZ - Kazakistan 11
NP - Nepal 11
PR - Porto Rico 10
SI - Slovenia 10
UY - Uruguay 10
ET - Etiopia 9
BO - Bolivia 8
DO - Repubblica Dominicana 8
PT - Portogallo 8
EE - Estonia 7
HN - Honduras 7
MD - Moldavia 7
OM - Oman 7
RS - Serbia 7
LB - Libano 6
SC - Seychelles 6
A2 - ???statistics.table.value.countryCode.A2??? 5
GT - Guatemala 5
HU - Ungheria 5
NI - Nicaragua 5
PA - Panama 5
AL - Albania 4
KG - Kirghizistan 4
NG - Nigeria 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
EU - Europa 3
LY - Libia 3
NZ - Nuova Zelanda 3
SN - Senegal 3
SV - El Salvador 3
Totale 38.038
Città #
Ashburn 1.958
Santa Clara 1.755
Fairfield 1.580
Singapore 1.440
Hong Kong 1.269
Southend 1.265
Chandler 1.039
Woodbridge 832
Houston 691
San Jose 656
Wilmington 571
Hefei 514
Cambridge 492
Seattle 467
Council Bluffs 456
Los Angeles 451
London 441
Jacksonville 440
Nyköping 407
Beijing 390
Chicago 369
Ann Arbor 331
Dearborn 326
Modena 307
The Dalles 300
Helsinki 288
Ho Chi Minh City 269
Seoul 245
Hanoi 228
New York 220
San Diego 219
Princeton 187
Sofia 170
Milan 164
Munich 138
Salt Lake City 138
Buffalo 128
Columbus 104
Moscow 103
Rome 94
Dublin 92
Dallas 88
São Paulo 82
Eugene 77
Shanghai 75
Tampa 74
Lauterbourg 72
Elk Grove Village 70
Jakarta 69
Izmir 68
Tokyo 62
Toronto 60
Bologna 58
Des Moines 58
Phoenix 57
Orem 55
Atlanta 52
Frankfurt am Main 51
Longmont 51
Da Nang 49
Falls Church 48
Warsaw 48
Istanbul 47
Fremont 46
Guangzhou 43
Denver 41
Haiphong 41
Redondo Beach 41
Redwood City 41
Montreal 40
Rio de Janeiro 40
Lancaster 39
Reggio Emilia 39
Norwalk 38
San Francisco 37
Brooklyn 36
Pittsburgh 36
Miami 35
Parma 35
Chennai 33
Johannesburg 32
Brno 31
Mexico City 31
Vancouver 31
Catania 30
Manchester 30
Belo Horizonte 29
Naples 29
Philadelphia 29
Sterling 29
Boardman 28
Miano 28
Brasília 27
Bremen 27
Poplar 27
Turku 26
Baghdad 25
Tashkent 25
Hải Dương 24
Nanjing 24
Totale 24.128
Nome #
Early neonatal inflammation affects adult pain reactivity and anxiety related traits in mice: genetic background counts 586
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression 518
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 503
Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats 491
Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders 488
N-acetyl-cysteine prevents toxic oxidative effects induced by IFN-α in human neurons. 486
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 458
Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus 457
Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in a rat model of depression 455
Disease-induced neuroinflammation and depression 454
Early postnatal chronic inflammation produces long-term changes in pain behavior and N-methyl-D-aspartate receptor subtype gene expression in the central nervous system of adult mice 440
Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment 414
Constitutive and LPS-regulated expression of interleukin-18 receptor beta variants in the mouse brain 407
Stress induces altered CRE/CREB pathway activity and BDNF expression in the hippocampus of glucocorticoid receptor-impaired mice 407
Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKK alpha and CaMKK beta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor 399
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study 394
Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 394
Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression 393
LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response 373
Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype 372
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 368
Behavioural and molecular effects of the combined treatment fluoxetine plus acetylsalicylic acid in a rat model of depression 368
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 357
Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. 355
Interferon alpha exposure increases the expression of the enzymes belonging to the kynurenine pathway in an in vitro model of human neurons: SH-SY5Y cells 354
Regulation of ionotropic glutamate receptors in the rat brain in response to the atypical antipsychotic seroquel (quetiapine fumarate). . 353
Cognitive deficits and changes in gene expression of NMDA receptors after prenatal methylmercury exposure 347
P.1.04 Expression of histone variants H3.3 and H2a.z in the rat brain: Physiopathological and pharmacological implications 344
Molecular changes associated with escitalopram response in a stress-based model of depression 342
Mitochondrial energy metabolism of rat hippocampus after treatment with the antidepressants desipramine and fluoxetine 339
Impaired stress-induced regulation of brain derived neurotrophic factor expression in hippocampus of glucocorticoid receptor impaired mice: Model of depression 338
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. 337
Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment 337
Effects of acute stress on brain-derived neurotrophic factor in the hippocampus of transgenic mouse model of depression 335
P.2.a.012 Co-administration of fluoxetine with acetylsalicylic acid, but not flurbiprofen or celecoxib, for one week shows an antidepressant-like effect 332
Lymnaea stagnalis as model for translational neuroscience research: from pond to bench 332
Erratum to: Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2 (J Neuroimmune Pharmacol, 2015, DOI 10.1007/s11481-015-9641-x) 332
Interleukin 18 activates MAPKs and STAT3 but not NF-κB in hippocampal HT-22 cells 331
Neonatal persistent inflammation alters pain response and NMDA receptor expression in adult mice 326
Interferon-alpha exposure increases the expression of enzymes of the kynurenine pathway and induces apoptosis in a model of human neurons 325
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 312
Hypothalamic expression of inflammatory mediators in an animal model of binge eating 312
Environmental enrichment influences mouse hippocampal neuroinflammatory response 309
VORTIOXETINE ATTENUATES NEUROINFLAMMATION BY MODULATING THE NOD-LIKE RECEPTOR FAMILY PYRIN DOMAIN CONTAINING 3 INFLAMMASOME ACTIVATION IN MICROGLIA: IMPLICATIONS FOR COGNITIVE FUNCTION 308
Mood stabilizers: protecting the mood ... protecting the brain 307
Cloning of mouse Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKKbeta) and characterization of CaMKKbeta and CaMKKalpha distribution in the adult mouse brain. 306
ADOLESCENCE AS A CRITICAL TIME-WINDOW FOR NEUROINFLAMMATION IN THE MOUSE: WHY SEX MATTERS 305
New combination therapies from animal to human 305
Molecular effects of subchronic andchronic treatment with escitalopram inthe rat central nervous system 303
Gene expression profile of the hippocampus of a behavioural model of depression 297
Combined effect of antidepressant and anti-inflammatory drugs in an animal model of depressio 297
Environmental quality modulates the endocannabinoid system along the gut-brain axis in a mouse model of LPS-induced neuroinflammation 296
Combined fluoxetine and metformin treatment potentiates antidepressant efficacy increasing IGF2 expression in the dorsal hippocampus 296
Restraint stress increases the expression of brain derived neurotrophic factor in the hippocampus of a mouse model of depression 295
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression 294
Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain 289
Vortioxetine Prevents Lipopolysaccharide-Induced Memory Impairment Without Inhibiting the Initial Inflammatory Cascade 289
Regulation of CREB function in rat frontal cortex after combined treatment with Fluoxetine and Olanzapine 287
Modulation of neuroplasticity-related targets following stress-induced acute escape deficit 281
HTR1B as a risk profile maker in psychiatric disorders:a review through motivation and memory 277
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 275
Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases 271
Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression 271
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 267
Deciphering the central immunomodulatory effects of a vortioxetine pretreatment on the LPS-induced inflammatory cascade 263
Metabolic changes induced by interferon-α exposure in an in vitro model of human neurons 257
Cyclic GMP inhibition of metabotropic glutamate receptor-induced phosphoinositide hydrolysis in mesencephalic neurons 255
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas 249
Dysbindin, D3 receptors, and their genetic interaction differently regulate neuroplasticity genes in the mouse brain 247
Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment 241
Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress 237
Interplay between inflammation and neural plasticity: Both immune activation and suppression impair LTP and BDNF expression 236
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment 234
Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit NMDA receptor activity and prevent neurotoxicity in mesencephalic neuron in vitro 231
Effect of idebenone on in vivo serotonin release and serotonergic receptors in young and aged rats 226
Metabolic characterization of SH-SY5Y cells and effects of interferon-alpha exposure 225
cAMP-dependent binding proteins and endogenous phosphorylation after antidepressant treatment 223
cAMP-dependent phosphorylation system after short and long-term administration of moclobemide 222
New insights into the biology of schizophrenia through the mechanism of action of clozapine. 213
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 213
Practical issues in clinical research of schizophrenia 206
cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity 204
cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment 204
Identification and characterization of the kynurenine pathway in the pond snail Lymnaea stagnalis 198
Behavioural and neurochemical changes produced by lefetamine in two inbred strains of mice 196
P.304 Executive functioning and genetic variation in pediatric patients with cancer 194
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: Dissociation from effects on prolactin secretion 191
Time- and Region-specific Effect of Vortioxetine on Central LPS-induced Transcriptional Regulation of NLRP3 Inflammasome 190
Chiralità e farmaci antidepressivi 189
Serum metabolic signature of binge-like palatable food consumption in female rats by nuclear magnetic resonance spectroscopy 188
Farmaci antidepressivi parte II: SNRI e farmaci multimodali 185
Second messenger-regulated protein kinases in the brain: Their functional role and the action of antidepressant drugs 185
Microglial diversity along the hippocampal longitudinal axis impacts synaptic plasticity in adult male mice under homeostatic conditions 183
Behavioural and biochemical effects in C57BL/6J mice after a prolonged treatment with the δ‐opiate antagonist ICI 154129 178
Role of dopamine D3 receptors, dysbindin, and their functional interaction on the expression of key genes for neuroplasticity in the mouse brain 174
BIOCHEMICAL AND MOLECULAR CHANGES IN RAT CEREBRAL CORTEX AFTER CHRONIC ANTIDEPRESSANT TREATMENT: ‘IN VITRO AND’‘IN VIVO’ STUDIES 173
Age-related changes in 5HT uptake and [3H]imipramine binding sites in rat cerebral cortex 173
Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies 171
Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine 170
Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: Interactions with reserpine 169
Totale 30.283
Categoria #
all - tutte 159.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.904


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.610 0 0 153 241 75 233 113 137 307 351 686 314
2022/20232.866 303 255 250 293 289 441 43 307 424 28 116 117
2023/20241.987 130 127 130 222 379 157 101 278 38 101 90 234
2024/20257.626 290 98 101 490 1.278 1.074 466 378 793 986 868 804
2025/202612.237 790 401 904 1.399 2.069 757 1.397 618 1.051 1.107 974 770
2026/20271.178 407 711 60 0 0 0 0 0 0 0 0 0
Totale 38.425